SRP286990 PRJNA668532 GSE159353 EphA2-SE-KO RNA-seq We used Crispr/Cas9 technology to establish a homozygous clone of EphA2-SE deletion in tumor cells. Wild-type cells (WT) and homozygous cloned cells (EphA2-SE-/-) were selected for high-throughput data detection. Overall design: mRNA profiles of WT and EphA2-SE-/- cells. GSE159353 pubmed 33712565